Prospective studies should be carried out to find out interventions that can significantly reduce the recurrence risk
To check the robustness of our estimations, we develop an alternative measure of conflict recurrence risk
without relying on the level and growth of domestic per capita income, presented in the second column of Table 1, and find that the estimated risk of conflict recurrence remains robust.
7) Women taking tamoxifen showed no difference in mortality or recurrence risk
associated with soy intake.
Locoregional recurrence risk
for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment [published online ahead of print April 7, 2014].
Our study shows a slightly higher recurrence risk
This recurrence risk
stratification system can provide promising guidance concerning the initial postoperative management of DTC, but it can also give rise to controversy.
Germinal mosaicism increases the recurrence risk
for "new" Duchenne muscular dystrophy mutations.
Before folic acid fortification in the United States, the NTD recurrence risk
was estimated to be about 2%-5% (3).
The recurrence risk
for a woman who has had a single child with an NTD is 2-5% and increases if more than one child is affected.
This study showed good outcomes with recurrence risk
reduction due to segmental resection, reliable mandibular reconstruction and less surgical procedures, allowing full rehabilitation within a shorter period of time and good esthetic and functional outcomes which improved quality of life.
two biomarkers for recurrence risk
assessment - the molecular grade index, which measures expression levels of five genes related to tumor proliferation; and the H and I ratio, which compares expression levels of two other genes.
2) provide genetic counseling, which will inform the family about the likely recurrence risk
of an ASD in future progeny, and
We used Student's t-test for the continuous variables with normal distribution, while the Mann-Whitney U-test was employed for the continuous variables outside the normal distribution between the ECV success and the recurrence risk
of the atrial fibrillation groups.
Parents can be reassured that the recurrence risk
for future pregnancies is low, as most affected individuals have de novo mutations.
Therefore the choice of adjuvant should be according to the environmental conditions, individual recurrence risk
factors and the surgeon's expertise.